News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,605 Results
Type
Article (2523)
Company Profile (39)
Press Release (38043)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14670)
Career Advice (77)
Deals (2165)
Drug Delivery (9)
Drug Development (4571)
Employer Resources (11)
FDA (470)
Job Trends (799)
News (21328)
Policy (1206)
Tag
Academia (151)
Allergies (6)
Alliances (3700)
ALS (6)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (24)
Approvals (474)
Artificial intelligence (13)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (504)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (21)
Cancer (194)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (16)
Cell therapy (49)
Cervical cancer (2)
Clinical research (3609)
Collaboration (108)
Company closure (1)
Compensation (52)
COVID-19 (193)
CRISPR (8)
C-suite (32)
Cystic fibrosis (2)
Data (155)
Denatured (3)
Depression (3)
Diabetes (14)
Diagnostics (485)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (16)
Drug pricing (7)
Duchenne muscular dystrophy (14)
Earnings (4421)
Editorial (3)
Employer branding (1)
Employer resources (9)
Events (6502)
Executive appointments (100)
FDA (531)
Funding (82)
Gene editing (16)
Gene therapy (23)
GLP-1 (66)
Government (159)
Guidances (2)
Healthcare (767)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (3)
Infectious disease (198)
Inflammatory bowel disease (12)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (1039)
IRA (7)
Job creations (296)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (41)
Leadership (1)
Legal (222)
Liver cancer (7)
Lung cancer (27)
Lymphoma (6)
Management (5)
Manufacturing (21)
MASH (4)
Medical device (338)
Medtech (338)
Mergers & acquisitions (1205)
Metabolic disorders (38)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (10)
Neuropsychiatric disorders (3)
Neuroscience (98)
NextGen: Class of 2025 (363)
Non-profit (154)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (12)
Pain (10)
Pancreatic cancer (5)
Parkinson's disease (5)
Partnered (2)
Patents (23)
Patient recruitment (8)
Peanut (1)
People (5773)
Pharmaceutical (5)
Phase I (1591)
Phase II (1753)
Phase III (946)
Pipeline (95)
Policy (13)
Postmarket research (30)
Preclinical (633)
Press Release (3)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (26)
Real estate (477)
Recruiting (5)
Regulatory (964)
Reports (6)
Research institute (145)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (13)
Series A (25)
Series B (7)
Service/supplier (2)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (495)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
Vaccines (31)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (18)
Last 7 days (84)
Last 30 days (272)
Last 365 days (2760)
2025 (971)
2024 (2813)
2023 (3128)
2022 (4086)
2021 (4428)
2020 (3695)
2019 (2201)
2018 (1659)
2017 (1887)
2016 (1689)
2015 (1901)
2014 (1409)
2013 (1222)
2012 (1438)
2011 (1391)
2010 (1246)
Location
Africa (44)
Alabama (1)
Arizona (15)
Asia (3566)
Australia (301)
California (955)
Canada (140)
China (137)
Colorado (21)
Connecticut (10)
Delaware (4)
Europe (3997)
Florida (44)
Georgia (6)
Idaho (3)
Illinois (18)
India (1)
Indiana (33)
Japan (10)
Kansas (12)
Maryland (64)
Massachusetts (332)
Michigan (9)
Minnesota (15)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (77)
New York (56)
North Carolina (93)
Northern California (430)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (55)
Rhode Island (2)
South America (41)
South Carolina (1)
Southern California (396)
Tennessee (2)
Texas (78)
United States (1968)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
40,605 Results for "suzhou zelgen biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China
October 30, 2024
·
2 min read
Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China
Gritgen Therapeutics Co., Ltd., a biotechnology company focused on discovering and developing innovative gene therapy products, announces the successful validation and official launching of operations at its commercial GMP facility located in Suzhou Industrial Park.
October 10, 2023
·
3 min read
BioMidwest
Nortech Systems Suzhou Facility Certified to Produce Class II Medical Devices for Asia Market
Nortech Systems Incorporated is proud to announce that its Suzhou, China facility has been certified by the National Medical Products Administration to produce Class II Medical Devices for customers in Asia.
October 4, 2023
·
3 min read
Business
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
111, Inc. (“111" or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Suzhou Zelgen Biopharmaceuticals Co., Ltd. (“Zelgen”) (688266.SH), an innovative drug R&D and production company.
August 3, 2021
·
7 min read
Drug Development
Suzhou OSAI Biopharma Announces Positive Phase III Clinical Trial Results for Lactobacillus Crispatus Live Bacteria Capsule, Significantly Reducing Recurrence of Gynecological Infections
Suzhou OSAI Biopharma, Inc., a biopharmaceutical company focused on developing live biotherapeutic products (LBPs), today announced that its Phase III clinical trial of vaginal L. crispatus live bacteria capsule (Lc262-1) has successfully met its primary and secondary endpoints.
December 12, 2023
·
4 min read
Press Releases
Junshi Biosciences Announces Toripalimab’s Approval in Singapore
March 27, 2025
·
7 min read
Press Releases
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
April 28, 2025
·
8 min read
Press Releases
Castle Biosciences to Acquire Previse
May 6, 2025
·
4 min read
Press Releases
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
March 31, 2025
·
11 min read
Suzhou Zelgen Biosciences Completes $62M B Round
Suzhou Zelgen Biosciences completed a $62M series B financing to support its portfolio of small molecule and biologic drug candidates.
January 16, 2018
·
1 min read
1 of 4,061
Next
